From our issue: A retrospective multihospital study found that severe adverse events occurred at similarly low rates with #ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts. #IDsky #Medsky
Explore
“Super-gonorrhoea” sounds alarming. What does it actually mean?
After #ECDC’s recent risk assessment on #ceftriaxone -resistant #gonorrhoea, our expert - Otilia Mårdh explains the resistance problem, local transmission in Europe and how to keep infections treatable.
